Welsh government reveals plans for pharmacy PrEP pilot

A pilot scheme making HIV drug pre-exposure prophylaxis (PrEP) “more accessible” via community pharmacies is set to begin in autumn 2025, the Welsh government has told C+D.

“Primary care will have a key role to play in the life course of HIV”

“We are working with health boards to finalise plans to pilot a model that will provide more convenient access to PrEP in the community,” a Welsh government spokesperson yesterday (December 12) told C+D .

“The pilot, which we anticipate will begin in autumn 2025, will include exploring the role pharmacists providing Wales’ national pharmacist independent prescribing service might play in making PrEP more accessible,” they said.

Read more: Draft HIV guidance backs website selling PrEP for Bitcoin

It comes after the cabinet secretary for health and social care in Wales Jeremy Miles last month (November 18) said that “a model providing more convenient access to PrEP in the community will be piloted”.

He added that an “awareness-raising campaign” will also run in the spring so that “all those at risk know about PrEP and how to access it”.

“Make access even easier”

“Although the use of PrEP continues to grow, we can make access even easier,” Miles said.

“PrEP is predominately used by gay, bisexual and other men who have sex with men but much less so by those in other at-risk groups,” he added, stressing that “making improvements to access will help address this”.

Read more: HIV: Government ‘exploring’ making PrEP available in pharmacies

And the “HIV action plan for Wales” – published in March last year – set out that “primary care will have a key role to play in the life course of HIV”.

“This will include support for prevention initiatives, normalising testing for HIV [and] supporting provision for PrEP,” it said.

Read more: Green Party pledges to make PrEP available in pharmacies and online

Meanwhile, the Royal Pharmaceutical Society (RPS) last month raised concerns over guidance on the use of PrEP that directed patients “unable or unwilling” to access it on the NHS to a website “not regulated by the General Pharmaceutical Council (GPhC)”.

And the body highlighted that the website “gives the option of purchasing PreP via Bitcoin”, a cryptocurrency.

Sign in or register for free

Molly Bowcott

Read more by Molly Bowcott

Molly Bowcott joined C+D as a digital reporter in October 2024 after graduating from a master’s in journalism at City, University of London. She previously worked as a news reporter at the U.S. Sun, covering business and politics, among other things.

Latest from Clinical

Slew of fentanyl patches ‘out of stock’ until December

 
• By 
 • comment

The government has issued a warning that multiple strengths of fentanyl delivered through transdermal patches will be out of stock until the end of the year.

RSV jab pilot to expand by ‘up to’ 200 pharmacies

 
• By 
 • comment

The DH has revealed plans to expand the pharmacy RSV vaccine programme by “up to 200 sites in identified target areas” in 2025/26 to “reverse the downward trend” in uptake.

Patient secures ‘urgent’ leukaemia treatment after Pharmacy First consultation

 
• By 
 • comment

A pharmacist has been hailed as “incredible” after she spotted a patient’s leukaemia red flags during an NHS Pharmacy First Plus consultation.

More from News

Contract timeline at a glance: What is happening when?

 
• By 
 • comment0

Following the announcement of the long-awaited pharmacy funding deal, C+D sets out a timeline of when changes are due to be implemented over the course of the next year…

‘Cannabliss’ pharmacist pair sanctioned for lack of ‘adequate safeguards’

 
• By 
 • comment0

Two pharmacists have received sanctions from the GPhC for failing to “provide assurance” that cannabis based medicinal products (CBMP) were “appropriately prescribed” with “adequate” safeguards in place.